More Americans with diabetes will get a break on their insulin costs in 2024. Sanofi is joining the nation’s two other major insulin manufacturers in offering either price caps or savings programs ...

Insulin remains one of the most important treatments for people living with diabetes. Whether someone has Type 1 diabetes or advanced Type 2 diabetes, insulin therapy helps control blood sugar levels, ...

In a March 16 press release, the French drugmaker, which currently has its U.S. headquarters in Bridgewater, said the changes are slated to go into effect Jan. 1, 2024. Along with cutting down the ...

Sanofi is cutting the list price of Lantus, its most widely prescribed insulin in the US, by 78% and establishing a $35 monthly cap for those with private insurance, the company announced Thursday.